Keyphrases
Inflammatory Bowel Disease
100%
Escherichia Coli
60%
Crohn's Disease
45%
Ulcerative Colitis
40%
Fecal Microbiota Transplantation
38%
Placebo
31%
Gut Microbiota
29%
Helicobacter Pylori (H. pylori)
28%
Hospitalized Patients
28%
Denmark
26%
Atypical Hemolytic Uremic Syndrome (aHUS)
25%
Fecal Samples
24%
Irritable Bowel Syndrome
22%
Fecal Calprotectin
21%
Ciprofloxacin
21%
Active Ulcerative Colitis
20%
Meta-analysis
20%
Randomized Placebo-controlled Trial
20%
Enterohemorrhagic Escherichia Coli
19%
Antibiotic Treatment
19%
Daycare Centers
19%
Systematic Meta-analysis
19%
Saccharomyces Boulardii
19%
Bacterial Enteritis
19%
Stool
18%
Ulcerative Colitis Patient
18%
Germany
17%
Nissle
17%
Diarrhea
17%
PPSV23
16%
MGN1703
15%
Microbial Diversity
15%
Risk Factors
15%
Day Care
15%
Intestinal Inflammation
15%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
15%
Immunology and Microbiology
Escherichia coli
76%
Inflammatory Bowel Disease
69%
Crohn's Disease
54%
Serotype
37%
Ulcerative Colitis
33%
Helicobacter Pylori
28%
Enteroaggregative Escherichia Coli
28%
Intestine Flora
24%
Verotoxin-Producing Escherichia Coli
23%
Gastroenteritis
23%
Pneumococcal Vaccine
19%
Immunosuppressive Drug
19%
Whole Genome Sequencing
18%
Lefitolimod
15%
Medicine and Dentistry
Inflammatory Bowel Disease
35%
Fecal Microbiota Transplantation
31%
Placebo
28%
Irritable Bowel Syndrome
21%
Clostridium Difficile Infection
21%
Escherichia coli
20%
Diseases
19%
Crohn's Disease
19%
Probiotics
19%
Infection
17%
Gut Microbiota
15%
Diagnosis
15%
